Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 601–700 of 1,018
A Brief Overview of Progranulin in Health and Disease
Bateman, A., Cheung, S., & Bennett, H. P. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8559-3_1 · Cited by 64
Beel, S., Herdewyn, S., Fazal, R., De Decker, M., Moisse, M., Robberecht, W., Van Den Bosch, L., & Van Damme, P. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0288-y · Cited by 61
Genetic screen in a large series of patients with primary progressive aphasia
Ramos, E. M., Dokuru, D. R., Van Berlo, V., Wojta, K., Wang, Q., Huang, A. Y., Miller, Z. A., Karydas, A. M., Bigio, E. H., Rogalski, E., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.10.009 · Cited by 63
Boeve, B., Bove, J., Brannelly, P., Brushaber, D., Coppola, G., Dever, R., Dheel, C., Dickerson, B., Dickinson, S., Faber, K., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4947 · Cited by 61
Self-citationSecreted Chaperones in Neurodegeneration
Chaplot, K., Jarvela, T. S., & Lindberg, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00268 · Cited by 66
Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation
Ito, H., Nakamura, M., Komure, O., Ayaki, T., Wate, R., Maruyama, H., Nakamura, Y., Fujita, K., Kaneko, S., Okamoto, Y., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0842-y · Cited by 68
Invited Article: The Alzheimer disease–frontotemporal lobar degeneration spectrum
van der Zee, J., Sleegers, K., & Broeckhoven, C. V. (2008) · Neurology · doi:10.1212/01.wnl.0000327523.52537.86 · Cited by 61
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
Bernardi, L., Tomaino, C., Anfossi, M., Gallo, M., Geracitano, S., Costanzo, A., Colao, R., Puccio, G., Frangipane, F., Curcio, S. A. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.005 · Cited by 64
The role of progranulin in arthritis
Wei, J., Hettinghouse, A., & Liu, C.-J. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13191 · Cited by 62
Progranulin is a stress-response factor in fibroblasts subjected to hypoxia and acidosis
Guerra, R. R., Kriazhev, L., Hernandez‐Blazquez, F. J., & Bateman, A. (2007) · Growth Factors · doi:10.1080/08977190701781222 · Cited by 66
Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test
Arrant, A. E., Filiano, A. J., Warmus, B. A., Hall, A. M., & Roberson, E. D. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12300 · Cited by 59
rs5848 Variant of Progranulin Gene Is a Risk of Alzheimer’s Disease in the Taiwanese Population
Lee, M.-J., Chen, T.-F., Cheng, T.-W., & Chiu, M.-J. (2011) · Neurodegenerative Diseases · doi:10.1159/000322538 · Cited by 60
Cognition and Amyotrophic Lateral Sclerosis (ALS)
Irwin, D. J., Lippa, C. F., & Swearer, J. M. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507301613 · Cited by 69
Progranulin mutations in Dutch familial frontotemporal lobar degeneration
Bronner, I. F., Rizzu, P., Seelaar, H., van Mil, S. E., Anar, B., Azmani, A., Kaat, L. D., Rosso, S. M., Heutink, P., & Swieten, J. C. V. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201772 · Cited by 66
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia
Benussi, A., Alberici, A., Samra, K., Russell, L. L., Greaves, C. V., Bocchetta, M., Ducharme, S., Finger, E. C., Fumagalli, G., Galimberti, D., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12485 · Cited by 67
Progranulin Reduction Is Associated With Increased Tau Phosphorylation in P301L Tau Transgenic Mice
Hosokawa, M., Arai, T., Masuda-Suzukake, M., Kondo, H., Matsuwaki, T., Nishihara, M., Hasegawa, M., & Akiyama, H. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000158 · Cited by 59
Sortilin Regulates Progranulin Action in Castration-Resistant Prostate Cancer Cells
Tanimoto, R., Morcavallo, A., Terracciano, M., Xu, S., Stefanello, M., Buraschi, S., Lu, K. G., Bagley, D. H., Gomella, L. G., Scotlandi, K., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1590 · Cited by 63
Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 67
Targeting Alzheimer's disease with gene and cell therapies
Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 60
Cacace, R., Heeman, B., Mossevelde, S. V., Roeck, A. D., Hoogmartens, J., Rijk, P. D., Gossye, H., Vos, K. D., Coster, W. D., Stražišar, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01976-3 · Cited by 66
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
Morenas-Rodríguez, E., Alcolea, D., Suárez-Calvet, M., Muñoz-Llahuna, L., Vilaplana, E., Sala, I., Subirana, A., Querol-Vilaseca, M., Carmona-Iragui, M., Illán-Gala, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44173-8 · Cited by 59
Dächsel, J. C., Ross, O. A., Mata, I. F., Kachergus, J. M., Toft, M., Cannon, A. D., Baker, M. C., Adamson, J. L., Hutton, M., Dickson, D. W., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0178-1 · Cited by 61
Self-citationNonaka, T., Masuda‐Suzukake, M., & Hasegawa, M. (2017) · Neuropathology · doi:10.1111/neup.12427 · Cited by 61
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
Ranganathan, R., Haque, S., Coley, K., Shepheard, S. R., Cooper‐Knock, J., & Kirby, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00684 · Cited by 62
Phenotypic Heterogeneity of the GRN Asp22fs Mutation in a Large Italian Kindred
Pietroboni, A. M., Fumagalli, G., Ghezzi, L., Fenoglio, C., Cortini, F., Serpente, M., Cantoni, C., Rotondo, E., Corti, P., Carecchio, M., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101704 · Cited by 59
Cortical Thickness in Frontotemporal Dementia, Mild Cognitive Impairment, and Alzheimer's Disease
Hartikainen, P., Räsänen, J., Julkunen, V., Niskanen, E., Hallikainen, M., Kivipelto, M., Vanninen, R., Remes, A. M., & Soininen, H. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112060 · Cited by 58
Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis
Vercellino, M., Grifoni, S., Romagnolo, A., Masera, S., Mattioda, A., Trebini, C., Chiavazza, C., Caligiana, L., Capello, E., Mancardi, G. L., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511406164 · Cited by 58
Behrens, M. I., Mukherjee, O., Tu, P.-H., Liscic, R. M., Grinberg, L. T., Carter, D., Paulsmeyer, K., Taylor-Reinwald, L., Gitcho, M., Norton, J. B., et al. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31803083f2 · Cited by 58
Genetics and Underlying Pathology of Dementia
Ferencz, B., & Gerritsen, L. (2015) · Neuropsychology Review · doi:10.1007/s11065-014-9276-3 · Cited by 73
Hu, S., Tai, C.-C., Li, Y.-H., & Wu, J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.077 · Cited by 60
Progranulin and TDP-43: Mechanistic Links and Future Directions
Kumar-Singh, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9625-0 · Cited by 57
Amyotrophic Lateral Sclerosis–Plus Syndrome With TAR DNA-Binding Protein-43 Pathology
McCluskey, L. F., Elman, L. B., Martinez-Lage, M., Van Deerlin, V., Yuan, W., Clay, D., Siderowf, A., & Trojanowski, J. Q. (2009) · Archives of Neurology · doi:10.1001/archneur.66.1.121 · Cited by 58
Frontotemporal Dementia in Elderly Individuals
Baborie, A., Griffiths, T. D., Jaros, E., Momeni, P., McKeith, I. G., Burn, D. J., Keir, G., Larner, A. J., Mann, D. M., & Perry, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3323 · Cited by 58
Self-citationAmado, D. A., Rieders, J. M., Diatta, F., Hernandez-Con, P., Singer, A., Mak, J. T., Zhang, J., Lancaster, E., Davidson, B. L., & Chen-Plotkin, A. S. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.013 · Cited by 58
Rashad, S., Niizuma, K., & Tominaga, T. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264447 · Cited by 66
Dopper, E. G. P., Chalos, V., Ghariq, E., den Heijer, T., Hafkemeijer, A., Jiskoot, L. C., de Koning, I., Seelaar, H., van Minkelen, R., van Osch, M. J. P., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.08.001 · Cited by 57
Mendsaikhan, A., Tooyama, I., Bellier, J.-P., Serrano, G. E., Sue, L. I., Lue, L.-F., Beach, T. G., & Walker, D. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0862-8 · Cited by 57
“In FTD, loss of function mutations in the GRN gene resulting in significantly reduced levels of PGRN protein lead to neurodegeneration [15].”
BackgroundInfluentialNeuropathological fingerprints of survival, atrophy and language in primary progressive aphasia
Mesulam, M. M., Coventry, C., Bigio, E. H., Sridhar, J., Gill, N. P., Fought, A. J., Zhang, H., Thompson, C. K., Geula, C., Gefen, T. D., et al. (2022) · Brain · doi:10.1093/brain/awab410 · Cited by 68
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia
Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Schwarz, C. G., Reid, R., Baker, M. C., Perkerson, R. B., Lowe, V. J., et al. (2015) · Brain and Language · doi:10.1016/j.bandl.2015.01.009 · Cited by 58
Self-citationGeser, F., Prvulovic, D., O’Dwyer, L., Hardiman, O., Bede, P., Bokde, A. L. W., Trojanowski, J. Q., & Hampel, H. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.011 · Cited by 56
Protein aggregation, misfolding and consequential human neurodegenerative diseases
Sami, N., Rahman, S., Kumar, V., Zaidi, S., Islam, A., Ali, S., Ahmad, F., & Hassan, M. I. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1286339 · Cited by 64
Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
Yousef, A., Robinson, J. L., Irwin, D. J., Byrne, M. D., Kwong, L. K., Lee, E. B., Xu, Y., Xie, S. X., Rennert, L., Suh, E., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0471-3 · Cited by 56
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17
Ghetti, B., Wszolek, Z. K., Boeve, B. F., Spina, S., & Goedert, M. (2011) · Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders · doi:10.1002/9781444341256.ch14 · Cited by 57
Self-citationWexler, E. M., Rosen, E., Lu, D., Osborn, G. E., Martin, E., Raybould, H., & Geschwind, D. H. (2011) · Science Signaling · doi:10.1126/scisignal.2002282 · Cited by 56
Remnestål, J., Öijerstedt, L., Ullgren, A., Olofsson, J., Bergström, S., Kultima, K., Ingelsson, M., Kilander, L., Uhlén, M., Månberg, A., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00198-y · Cited by 56
Alquezar, C., Schoch, K. M., Geier, E. G., Ramos, E. M., Scrivo, A., Li, K. H., Argouarch, A. R., Mlynarski, E. E., Dombroski, B., DeTure, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3897 · Cited by 56
Self-citationWojtas, A., Heggeli, K., Finch, N. A., Baker, M. C., DeJesus‐Hernandez, M., Younkin, S. G., Dickson, D. W., Graff‐Radford, N. R., & Rademakers, R. (2012) · Europe PMC (PubMed Central) · Cited by 70
Self-citationNeuroprotective effects of progranulin in ischemic mice
Jiang, T., Ji, F., Wang, F., Liu, B., & Zhu, Y. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.063 · Cited by 56
Novel exon 1 progranulin gene variant in Alzheimer’s disease
Cortini, F., Fenoglio, C., Guidi, I., Venturelli, E., Pomati, S., Marcone, A., Scalabrini, D., Villa, C., Clerici, F., Dalla Valle, E., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02266.x · Cited by 56
Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity
Tian, Q., Zhao, Y., Mundra, J. J., Gonzalez-Gugel, E., Jian, J., Uddin, S. M. Z., & Liu, C. (2014) · Frontiers in bioscience · doi:10.2741/4274 · Cited by 56
Saracino, D., Dorgham, K., Camuzat, A., Rinaldi, D., Rametti-Lacroux, A., Houot, M., Clot, F., Martin-Hardy, P., Jornea, L., Azuar, C., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326914 · Cited by 55
Neumann, M., Igaz, L. M., Kwong, L. K., Nakashima‐Yasuda, H., Kolb, S. J., Dreyfuss, G., Kretzschmar, H. A., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0221-x · Cited by 56
Rosen, H. J., Boeve, B. F., & Boxer, A. L. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12004 · Cited by 55
Self-citationGijselinck, I., Engelborghs, S., Maes, G., Cuijt, I., Peeters, K., Mattheijssens, M., Joris, G., Cras, P., Martin, J.-J., De Deyn, P. P., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.82 · Cited by 55
Guerreiro, R., Bras, J., Hardy, J., & Singleton, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu203 · Cited by 55
Armstrong, R. A., Ellis, W., Hamilton, R. L., Mackenzie, I. R. A., Hedreen, J., Gearing, M., Montine, T., Vonsattel, J.-P., Head, E., Lieberman, A. P., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0350-6 · Cited by 55
Self-citationNedachi, T., Kawai, T., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.037 · Cited by 56
Kocerha, J., Kouri, N., Baker, M., Finch, N., DeJesus-Hernandez, M., Gonzalez, J., Chidamparam, K., Josephs, K. A., Boeve, B. F., Graff-Radford, N. R., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-527 · Cited by 55
Self-citationRecent insights into the molecular genetics of dementia
Rademakers, R., & Rovelet-Lecrux, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.005 · Cited by 55
Self-citationAbhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia
Kerchner, G. A., Tartaglia, M. C., & Boxer, A. L. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.6 · Cited by 59
C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease
Amick, J., & Ferguson, S. M. (2017) · Traffic · doi:10.1111/tra.12477 · Cited by 55
Sharma, J., di Ronza, A., Lotfi, P., & Sardiello, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061804 · Cited by 55
Sha, S. J., Hou, C. E., Viskontas, I. V., & Miller, B. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0357 · Cited by 63
Van Deerlin, V. M., Wood, E. M., Moore, P., Yuan, W., Forman, M. S., Clark, C. M., Neumann, M., Kwong, L. K., Trojanowski, J. Q., Lee, V. M.-Y., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1148 · Cited by 55
Right Temporal Lobe Atrophy: A Case That Initially Presented as Excessive Piety
Everhart, D. E., Watson, E. M., Bickel, K. L., & Stephenson, A. J. (2015) · The Clinical Neuropsychologist · doi:10.1080/13854046.2015.1104387 · Cited by 56
Mundra, J. J., Jian, J., Bhagat, P., & Liu, C.-J. (2016) · Scientific Reports · doi:10.1038/srep21115 · Cited by 55
Biomarkers for dementia in Latin American countries: Gaps and opportunities
Parra, M. A., Orellana, P., Leon, T., Victoria, C. G., Henriquez, F., Gomez, R., Avalos, C., Damian, A., Slachevsky, A., Ibañez, A., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12757 · Cited by 54
Promoter DNA methylation regulates progranulin expression and is altered in FTLD
Banzhaf-Strathmann, J., Claus, R., Mücke, O., Rentzsch, K., van der Zee, J., Engelborghs, S., De Deyn, P. P., Cruts, M., van Broeckhoven, C., Plass, C., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-16 · Cited by 54
Loss of exosomes in progranulin-associated frontotemporal dementia
Benussi, L., Ciani, M., Tonoli, E., Morbin, M., Palamara, L., Albani, D., Fusco, F., Forloni, G., Glionna, M., Baco, M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.001 · Cited by 54
Viswanathan, J., Mäkinen, P., Helisalmi, S., Haapasalo, A., Soininen, H., & Hiltunen, M. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30889 · Cited by 54
Clinicopathologic correlation in PGRN mutations
Davion, S., Johnson, N., Weintraub, S., Mesulam, M. M., Engberg, A., Mishra, M., Baker, M., Adamson, J., Hutton, M., Rademakers, R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267701.58488.69 · Cited by 55
Self-citationRohrer, J. D., Warren, J. D., Omar, R., Mead, S., Beck, J., Revesz, T., Holton, J., Stevens, J. M., Al-Sarraj, S., Pickering-Brown, S. M., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.506 · Cited by 55
Self-citationFTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
Padhi, A. K., Kumar, H., Vasaikar, S. V., Jayaram, B., & Gomes, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032479 · Cited by 59
Tsuruma, K., Yamauchi, M., Sugitani, S., Otsuka, T., Ohno, Y., Nagahara, Y., Ikegame, Y., Shimazawa, M., Yoshimura, S., Iwama, T., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0020 · Cited by 55
Crisford, H., Sapey, E., & Stockley, R. A. (2018) · Respiratory Research · doi:10.1186/s12931-018-0883-z · Cited by 57
Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers
Lee, S. E., Sias, A. C., Kosik, E. L., Flagan, T. M., Deng, J., Chu, S. A., Brown, J. A., Vidovszky, A. A., Ramos, E. M., Gorno-Tempini, M. L., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101751 · Cited by 53
Self-citationAdvances in treatment of frontotemporal dementia
Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.21060166 · Cited by 52
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Cognitively healthy centenarians are genetically protected against Alzheimer's disease
Tesi, N., van der Lee, S., Hulsman, M., van Schoor, N. M., Huisman, M., Pijnenburg, Y., van der Flier, W. M., Reinders, M., & Holstege, H. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13810 · Cited by 52
Martínez, A., Carmona, M., Portero-Otin, M., Naudí, A., Pamplona, R., & Ferrer, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e06f3 · Cited by 52
Gascon, E., & Gao, F.-B. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.876021 · Cited by 52
The Genetics of Monogenic Frontotemporal Dementia
Takada, L. T. (2015) · Dementia & Neuropsychologia · doi:10.1590/1980-57642015dn93000003 · Cited by 60
Alzheimer disease: modeling an Aβ-centered biological network
Campion, D., Pottier, C. P., Nicolas, G., Guennec, K. L., & Rovelet‐Lecrux, A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.38 · Cited by 62
Medina, D. X., Orr, M. E., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.006 · Cited by 53
The genetics of frontotemporal lobar degeneration
Rademakers, R., & Hutton, M. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0067-6 · Cited by 56
Self-citationUpdate on Frontotemporal Dementia
Arvanitakis, Z. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181b1d5c6 · Cited by 51
Borroni, B., Bonvicini, C., Galimberti, D., Tremolizzo, L., Papetti, A., Archetti, S., Turla, M., Alberici, A., Agosti, C., Premi, E., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.009 · Cited by 57
Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review
Pan, X.-D., & Chen, X.-C. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-8 · Cited by 52
Borroni, B., Archetti, S., Alberici, A., Agosti, C., Gennarelli, M., Bigni, B., Bonvicini, C., Ferrari, M., Bellelli, G., Galimberti, D., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0127-3 · Cited by 56
Growth Factors as Active Participants in Carcinogenesis: A Perspective
Halper, J. T. (2009) · Veterinary Pathology · doi:10.1177/0300985809352981 · Cited by 62
Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation
Cruchaga, C., Fernández-Seara, M. A., Seijo-Martínez, M., Samaranch, L., Lorenzo, E., Hinrichs, A., Irigoyen, J., Maestro, C., Prieto, E., Martí-Climent, J. M., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn202 · Cited by 50
TMEM106B expression is reduced in Alzheimer’s disease brains
Satoh, J.-I., Kino, Y., Kawana, N., Yamamoto, Y., Ishida, T., Saito, Y., & Arima, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt247 · Cited by 51
Progranulin overexpression in sensory neurons attenuates neuropathic pain in mice: Role of autophagy
Altmann, C., Hardt, S., Fischer, C., Heidler, J., Lim, H.-Y., Häussler, A., Albuquerque, B., Zimmer, B., Möser, C., Behrends, C., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.010 · Cited by 51
Fu, W., Hu, W., Shi, L., Mundra, J. J., Xiao, G., Dustin, M. L., & Liu, C.-J. (2016) · The FASEB Journal · doi:10.1096/fj.201601134r · Cited by 53
Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis
Chen, Y., Li, S., Su, L., Sheng, J., Lv, W., Chen, G., & Xu, Z. (2015) · Journal of Neurology · doi:10.1007/s00415-014-7630-2 · Cited by 50
Marian, O. C., Teo, J. D., Lee, J. Y., Song, H., Kwok, J. B., Landin-Romero, R., Halliday, G., & Don, A. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01544-7 · Cited by 50
Nelson, P. T., Fardo, D. W., Wu, X., Aung, K. Z., Cykowski, M. D., & Katsumata, Y. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae032 · Cited by 58
Colella, P., Sayana, R., Suárez-Nieto, M. V., Sarno, J., Nyame, K., Xiong, J., Vera, L. N. P., Basurto, J. A., Corbo, M., Limaye, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49908-4 · Cited by 59
GRN Variant rs5848 Reduces Plasma and Brain Levels of Granulin in Alzheimer's Disease Patients
Kämäläinen, A., Viswanathan, J., Natunen, T., Helisalmi, S., Kauppinen, T., Pikkarainen, M., Pursiheimo, J.-P., Alafuzoff, I., Kivipelto, M., Haapasalo, A., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120946 · Cited by 50
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.